# Eton Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/eton-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 15 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-10T04:46:00.802388+00:00 | | Last reviewed | 2026-10-10T04:46:00.802388+00:00 | ## Identity - Legal name: Eton Pharmaceuticals, Inc. - Display name: Eton Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-10T07:08:53.82387+00:00 | | Completeness | 0.409 | | Record Quality | 0.822 | | Directors | 7 | | Committees | 1 | | Governance events | 5 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles J. Casamento: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:6 - Gruber Employment Agreement: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-04-25. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:7 - Ipek Erdogan-Trinkaus: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-04-25. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:8 - Jenn Adams: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:9 - Paul V. Maier: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:10 - Norbert G. Riedel: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:5 - Sean E. Brynjelsen: Director, President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Chief Executive Officer (member). claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:11 ## Committees - President and Chief Executive Officer (executive). Chair: NOT_PUBLISHED. Members: Sean E. Brynjelsen (member, unknown). committee_id=alpha:committee:eton-pharmaceuticals-inc:president-and-chief-executive-officer ## Executive leadership - David C. Krempa: Chief Business Officer. Status: unknown. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:12 - Ipek Erdogan-Trinkaus: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:13 - James R. Gruber: Chief Financial Officer, Treasurer, and Secretary [CFO]. Status: unknown. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:14 - Sean E. Brynjelsen: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:15 ## Governance events - DIRECTOR_APPOINTED: Gruber Employment Agreement seat on Eton Pharmaceuticals, Inc., effective 2025-04-25. Effective: 2025-04-25. Detected: 2026-10-10T04:46:00.802388+00:00. event_id=alpha:event:transition:109dk18izeeuk - DIRECTOR_APPOINTED: Ipek Erdogan-Trinkaus seat on Eton Pharmaceuticals, Inc., effective 2025-04-25. Effective: 2025-04-25. Detected: 2026-10-10T04:46:00.802388+00:00. event_id=alpha:event:transition:1tegq4513p1vx3 - DIRECTOR_APPOINTED: Jenn Adams seat on Eton Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-10T04:46:00.802388+00:00. event_id=alpha:event:transition:1no3uwh14bp1kd - DIRECTOR_APPOINTED: Charles J. Casamento seat on Eton Pharmaceuticals, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-10T04:46:00.802388+00:00. event_id=alpha:event:transition:1u3ong1x98sq3 - DIRECTOR_APPOINTED: Paul V. Maier seat on Eton Pharmaceuticals, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-10T04:46:00.802388+00:00. event_id=alpha:event:transition:14rybm0112shpk ## Scoped resources - `alpha://company/eton-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record - `alpha://company/eton-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/eton-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/eton-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=board - `alpha://company/eton-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/eton-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/eton-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/eton-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/eton-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/eton-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/eton-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/eton-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/eton-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/eton-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/eton-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/eton-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/eton-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/eton-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/eton-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/eton-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=events - `alpha://company/eton-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/eton-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/eton-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Norbert G. Riedel: Chairman of the Board. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8ad30ab0d55067a4071e3b1e264a872c7caf239428acfaf8c0a8fb6485e48d9. - Charles J. Casamento: Director. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:6. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26f294ca01ab5f5cbc61e59f44bbc2068d85b4923b58da15a0d67dbe47c23d19. - Gruber Employment Agreement: Director. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:7. Valid from: 2025-04-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26f294ca01ab5f5cbc61e59f44bbc2068d85b4923b58da15a0d67dbe47c23d19. - Ipek Erdogan-Trinkaus: Director. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:8. Valid from: 2025-04-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26f294ca01ab5f5cbc61e59f44bbc2068d85b4923b58da15a0d67dbe47c23d19. - Jenn Adams: Director. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26f294ca01ab5f5cbc61e59f44bbc2068d85b4923b58da15a0d67dbe47c23d19. - Paul V. Maier: Director. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26f294ca01ab5f5cbc61e59f44bbc2068d85b4923b58da15a0d67dbe47c23d19. - Sean E. Brynjelsen: Director, President and Chief Executive Officer. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8ad30ab0d55067a4071e3b1e264a872c7caf239428acfaf8c0a8fb6485e48d9. - David C. Krempa: Chief Business Officer. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8ad30ab0d55067a4071e3b1e264a872c7caf239428acfaf8c0a8fb6485e48d9. - Ipek Erdogan-Trinkaus: Chief Commercial Officer. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8ad30ab0d55067a4071e3b1e264a872c7caf239428acfaf8c0a8fb6485e48d9. - James R. Gruber: Chief Financial Officer, Treasurer, and Secretary. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8ad30ab0d55067a4071e3b1e264a872c7caf239428acfaf8c0a8fb6485e48d9. - Sean E. Brynjelsen: President and Chief Executive Officer. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8ad30ab0d55067a4071e3b1e264a872c7caf239428acfaf8c0a8fb6485e48d9. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Eton Pharmaceuticals, Inc.. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f1ca749fdcda9ead75e01521682d29e4a870490eb41dd269889059ecb4f9be85. ## Entity Status - Public listing published. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f1ca749fdcda9ead75e01521682d29e4a870490eb41dd269889059ecb4f9be85. ## Published Fact - US. Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f1ca749fdcda9ead75e01521682d29e4a870490eb41dd269889059ecb4f9be85. ## Security Listing - ETON (NASDAQ). Claim: alpha:claim:company:1ba1905d-97d3-4c0e-920b-82fc93a2fd6b:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f1ca749fdcda9ead75e01521682d29e4a870490eb41dd269889059ecb4f9be85. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:f1ca749fdcda9ead75e01521682d29e4a870490eb41dd269889059ecb4f9be85: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/eton-pharmaceuticals-inc). - alpha:projection-evidence:document:c8ad30ab0d55067a4071e3b1e264a872c7caf239428acfaf8c0a8fb6485e48d9: [SEC DEF 14A 0001437749-26-013313](https://www.sec.gov/Archives/edgar/data/1710340/000143774926013313/eton20251124_def14a.htm). - alpha:projection-evidence:document:26f294ca01ab5f5cbc61e59f44bbc2068d85b4923b58da15a0d67dbe47c23d19: [DEF 14A eton20250423_def14a.htm](https://www.sec.gov/Archives/edgar/data/1710340/000143774925013137/eton20250423_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/eton-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/eton-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/eton-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/eton-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-10T07:08:53.656147+00:00; recorded 2026-10-10T07:08:53.656147+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.